AbstractEmpirical evidence suggests that levodopa medication used to treat the motor symptoms of Parkinson's disease (PD) may either improve, impair or not affect specific cognitive processes. This evidence led to the ‘dopamine overdose’ hypothesis that levodopa medication impairs performance on cognitive tasks if they recruit fronto-striatal circuits which are not yet dopamine-depleted in early PD and as a result the medication leads to an excess of dopamine. This hypothesis has been supported for various learning tasks including conditional associative learning, reversal learning, classification learning and intentional deterministic sequence learning, on all of which PD patients demonstrated significantly worse performance when tested on...
To study the interaction between levodopa and the feedback process on set-shifting in Parkinson's di...
Cognitive dysfunction is a feature of Parkinson’s Disease (PD). Some cognitive functions are impair...
Response fluctuations in motor function, complicating long-term dopaminomimetic therapy of Parkinson...
Empirical evidence suggests that levodopa medication used to treat the motor symptoms of Parkinson's...
Empirical evidence suggests that levodopa medication used to treat the motor symptoms of Parkinson’s...
AbstractEmpirical evidence suggests that levodopa medication used to treat the motor symptoms of Par...
The mesocorticolimbic dopamine (DA) system linking the dopaminergic midbrain to the prefrontal corte...
The present study was aimed at investigating the effect of acute levodopa administration on the perf...
Previous studies on movement sequence learning in Parkinson's disease (PD) have produced mixed resul...
CONTEXT: Subthalamic nucleus deep brain stimulation (STN-DBS) and levodopa therapy are reported to p...
The spatiotemporal progression of dopamine depletion in Parkinson's disease (PD) provides a special ...
Growing interest is present in literature on the study of prospective memory functioning in Parkinso...
About a half a century has passed since dopamine was identified as a neurotransmitter, and it has be...
In this study we examined the effect of dopaminergic modulation on learning and memory. Parkinson’s ...
Background/Aims: Levodopa and dopamine agonists have different effects on the motor, cognitive, and ...
To study the interaction between levodopa and the feedback process on set-shifting in Parkinson's di...
Cognitive dysfunction is a feature of Parkinson’s Disease (PD). Some cognitive functions are impair...
Response fluctuations in motor function, complicating long-term dopaminomimetic therapy of Parkinson...
Empirical evidence suggests that levodopa medication used to treat the motor symptoms of Parkinson's...
Empirical evidence suggests that levodopa medication used to treat the motor symptoms of Parkinson’s...
AbstractEmpirical evidence suggests that levodopa medication used to treat the motor symptoms of Par...
The mesocorticolimbic dopamine (DA) system linking the dopaminergic midbrain to the prefrontal corte...
The present study was aimed at investigating the effect of acute levodopa administration on the perf...
Previous studies on movement sequence learning in Parkinson's disease (PD) have produced mixed resul...
CONTEXT: Subthalamic nucleus deep brain stimulation (STN-DBS) and levodopa therapy are reported to p...
The spatiotemporal progression of dopamine depletion in Parkinson's disease (PD) provides a special ...
Growing interest is present in literature on the study of prospective memory functioning in Parkinso...
About a half a century has passed since dopamine was identified as a neurotransmitter, and it has be...
In this study we examined the effect of dopaminergic modulation on learning and memory. Parkinson’s ...
Background/Aims: Levodopa and dopamine agonists have different effects on the motor, cognitive, and ...
To study the interaction between levodopa and the feedback process on set-shifting in Parkinson's di...
Cognitive dysfunction is a feature of Parkinson’s Disease (PD). Some cognitive functions are impair...
Response fluctuations in motor function, complicating long-term dopaminomimetic therapy of Parkinson...